Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tracing the lineage of replicative RNAs in the process of KRAS (S17N) evolution

ABSTRACT: Tracing the lineage of replicative RNAs in the process of KRAS (S17N) evolution

PROVIDER: PRJNA1133787 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29759500_subreads.fastq.gz	Fastqsanger.gz
	SRR29759501_subreads.fastq.gz	Fastqsanger.gz
	SRR29759502_subreads.fastq.gz	Fastqsanger.gz
	SRR29759503_subreads.fastq.gz	Fastqsanger.gz
	SRR29759504_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 13

Similar Datasets

Tracing the lineage of replicative RNAs in the process of KRAS (S17N) evolution

Project description:A dominant-negative gene therapy approach has been proposed and tested on proto-oncogene KRAS, wherein the oncogenic activity (and cell proliferation) of KRAS can be suppressed by introducing a dominant-negative KRAS allele (S17N). We employed REPLACE to conduct continuous evolution on KRAS (S17N) and examined its potential pathways for conferring resistance in this gene therapy methodology.To explore the accumulation of mutations in various RNAs during the KRAS (S17N) evolution experiment, we established a barcoded library and conducted lineage tracing of replicative RNAs carrying KRAS (S17N) throughout the evolution process.

2024-09-30 | GSE271874 | GEO

Tracing the lineage of replicative RNAs carrying MEK1 in the evolution of drug resistance

Project description:Drug resistance poses a significant clinical challenge, and comprehending the mechanisms underlying this resistance can facilitate the design of novel inhibitors and advance cancer treatment. The REPLACE system was employed to examine resistance mutations in MEK1 during the administration of 3 allosteric inhibitors. To explore the accumulation of mutations in various RNAs during the MEK1 evolution experiment, we established a barcoded library and conducted lineage tracing of replicative RNAs carrying MEK1 throughout the drug resistance evolution process.

2024-09-30 | GSE271875 | GEO

Tracing the lineage of replicative RNAs carrying MEK1 in the evolution of drug resistance

Project description:Tracing the lineage of replicative RNAs carrying MEK1 in the evolution of drug resistance

| PRJNA1133786 | ENA

Tracing the evolution of single-cell 3D genomes in Kras-driven cancers

Project description:Tracing the evolution of single-cell 3D genomes in Kras-driven cancers

| PRJNA1256505 | ENA

Tracing the evolution of single-cell 3D genomes in Kras-driven cancers

Project description:Tracing the evolution of single-cell 3D genomes in Kras-driven cancers

| PRJNA1151718 | ENA

Tracing the evolution of single-cell 3D genomes in Kras-driven cancers

Project description:Although three-dimensional (3D) genome structures are altered in cancer cells, little is known about how these changes evolve and diversify during cancer progression. Leveraging genome-wide chromatin tracing to visualize 3D genome folding directly in tissues, we generated 3D genome cancer atlases of oncogenic Kras-driven murine lung and pancreatic adenocarcinoma. Our data reveal stereotypical, non-monotonic, and stage-specific alterations in 3D genome folding compaction, heterogeneity, and compartmentalization as cancers progress from normal to preinvasive and ultimately to invasive tumors, discovering a potential structural bottleneck in early tumor progression. Remarkably, 3D genome architectures distinguish morphologic cancer states in single cells, despite considerable cell-to-cell heterogeneity. Gene-level analyses of evolutionary changes in 3D genome compartmentalization not only showed that compartment-associated genes are more homogeneously regulated but also elucidated prognostic and dependency genes in lung adenocarcinoma and a previously unappreciated role for polycomb-group protein Rnf2 in 3D genome regulation. Our results demonstrate the utility of mapping the single-cell cancer 3D genome in tissues and illuminate its potential to identify new diagnostic, prognostic, and therapeutic biomarkers in cancer.

2025-05-02 | GSE295857 | GEO

Tracing the evolution of single-cell 3D genomes in Kras-driven cancers

2025-05-24 | GSE275588 | GEO

Tracing the evolution of single-cell 3D genomes in Kras-driven cancers [snRNA-seq]

2025-05-24 | GSE295452 | GEO

Analyzing the process of mutation accumulation in KRAS evolution experiment using amplicon sequencing

Project description:Directed evolution in mammalian cells can facilitate the engineering of mammalian-compatible biomolecules and can enable synthetic evolvability for mammalian cells. We engineered an orthogonal alphaviral RNA replication system to evolve synthetic RNA-based devices, enabling RNA replicase-assisted continuous evolution (REPLACE) in live mammalian cells. Using REPLACE, we attempted continuous intracellular evolution of the negative dominant mutant KRAS (S17N). To analyze the process of mutation accumulation, we performed amplicon sequencing on experimental materials at different stages and under different treatment conditions. The results indicated that the mutations generated by this system were primarily induced by Monanunavir, and the addition of Monanunavir significantly accelerated the rate of evolution.

2024-07-07 | GSE235327 | GEO

Tracing the evolution of single-cell 3D genomes in Kras-driven cancers [snRNA-seq]

Project description:Tracing the evolution of single-cell 3D genomes in Kras-driven cancers [snRNA-seq]

| PRJNA1254700 | ENA